Exosens shares fall 16.5% over three months and struggle to rebound
The Bordeaux-based optronics company recovers in mid-afternoon, in a Paris market trading higher. This rebound follows a multi-month low touched at the end of last week, and the stock remains well below its medium-term benchmarks.
A rebound that leaves the stock far from its moving averages
Exosens shares gain 2.32% to €52.85 during the session, while the SBF 120 rises by about 1%. The move follows the decline of the previous week, which had pushed the price below €52.15 with a 150-session low.
The price nevertheless remains 6.58% below its 20-day moving average (MM20) and 12.28% below its 200-day moving average (MM200), placing the rebound within a still-bearish underlying trend.
The stock has fallen 7.12% over seven days and 16.44% over three months, a decline that the gain of the day only partially offsets. It ranks among the gainers of the SBF 120 without being part of the leading group, led by Mersen (+4.48%) and Medincell.
Validated climate targets and a strong Q3 as a backdrop
On October 27, the group had published a third-quarter revenue of €133.8 million, up 23.5%, with a gross margin that declined. On November 5, Exosens announced that its 2030 climate targets were validated by the SBTi, with a targeted 42% reduction in emissions. Neither of these announcements had halted the decline of the previous week.
From a technical standpoint, the RSI at 38 remains in a low neutral zone, and the €51.65 support, which corresponds to the previous close, marks the level to watch on the downside. Analysts are following the consensus on the stock, with the nearest resistance at €61.10.
